 |
Emerging information on the use of rituximab in chronic
lymphocytic leukemia. Semin Oncol. 2002 Feb;29(1 Suppl 2):70-4.
Review. PMID: 11842391 - PubMed
|
|
X-rays considered for carcinogen list Government move highlights cancer risk
- USAToday
Dec_02
|
|
Cancer Docs Differ on Main Point of Medical Trials -
Reuters Dec_27_02
|
|
ASH 2002: Proleukin®
Plus Rituxan® may Reduce Recurrences Following Stem Cell Transplant
in Non-Hodgkin’s Lymphoma - CancerConsultants.com
|
| New
Chemotherapy Schedule for Breast Cancer Saves Lives - abcnews
Dec_12_02 "... shorter schedule seems to give cancer
cells less time to recuperate and grow between chemotherapy
treatments." Might this apply to NHL as well?
|
| Search ASH 2002 -
abstracts
(Free login req.)
|
| Amifostine: A
Useful Radioprotectant - Oncology
Review
|
|
|
| INEX achieves positive pivotal Phase II/III clinical trial results to seek FDA marketing approval for Onco TCS (liposomal vincristine) for relapsed aggressive non-Hodgkin's lymphoma (NHL). -
Newswire
Dec_03_02
|
| Is chronic lymphocytic leukemia one disease? - .haematologica.it/2002
"... monitoring the expression of a very limited number of genes might suffice to identify patients displaying an indolent disease from patients exhibiting an aggressive one."
|
| Pathogenic
moulds (including Aspergillus spp.) in hospital water
distribution systems: A three-year prospective study and clinical
implications for patients with hematological malignancies - Blood
-Nov_22_02
|
| Corixa Bexxar Review For Non-Hodgkin’s Lymphoma Set For Half-Day Meeting -
fdaadvisorycommittee.com
12_06_02
|
| Treatment
of cutaneous T cell lymphoma: current status and future directions. Am
J Clin Dermatol. 2002;3(3):193-215. Review. PMID: 11978140 - PubMed
|
| Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma
Julie M. Vose, Brian C.-H. Chiu, Bruce D. Cheson, Janet Dancey and John Wright
(Posted Nov_28_02) Abstract - asheducationbook.org
|
| Lymphoma of the Skin
Joseph M. Connors, Eric D. Hsi and Francine M. Foss Abstract- asheducationbook.org
|
| Combined
therapy in advanced stages (III and IV) of follicular lymphoma
increases the possibility of cure: results of a large controlled
clinical trial. [in patients with nodal bulky disease] - Eur J
Haematol 2002: 68: 144-149 - PDF
| PDFHelp
|
| Future of Monoclonal Antibodies in the Treatment of Hematologic Malignancies from Cancer Control: Journal of the Moffitt Cancer Center Mitchell E.
Reff, PhD, Kandasamy Hariharan, PhD, and Gary Braslawsky, PhD -
Medscape (free login req.)
|
| Cancer Vaccines for Hematologic Malignancies from Cancer Control: Journal of the Moffitt Cancer Center
Ivan M. Borrello, MD, Eduardo M. Sotomayor, MD - Medscape (free login req.)
|
| A comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas -
Blood
Nov_21_02
|
| Durable Remissions Obtained with Zevalin in Recurrent Follicular Lymphoma -
CancerConsultants.com Nov_8_02
|
| Non-AIDS-associated NHL incidence has
continued to increase steadily through 1998. - J Natl Cancer
Inst. 2002 Aug 21;94(16):1204-10. PMID: 12189223 - PubMed
|
| They can analyze thousands of genes at a time. Here's how. -
techreview
|
| Of interest to pts with MALT: Randomized trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia -
BMJ 2002;324:999 (27 April)
|
| Radiation doses in computed tomography - The increasing doses of radiation need to be controlled -
BMJ 2000;320:593-594 (4 March)
|
| Radiation dose in [CT] scans could be halved -
BMJ 2001;323:185 (28 July)
|
| The U.S. government released its first
state-by-state report on cancer -
PDF | PDF-Help This is a
large 285 pg report that will take considerable time to open and
print.
|
| NCI: Strategic Plan For
Addressing the Recommendations of the Leukemia, Lymphoma, and
Myeloma Progress Review Group - PDF
| PDF-Help This is important 60
page document will take a good while to open & print.
Nov_2002
|
| Cancer Suppression Gene Identified - HealthScoutNews
Nov_16_02
|
| Onco TCS: first-line treatment for the
aggressive form of NHL Will it replace the current standard,
CHOP + Rituxan? - INEX
11_07_2
|
| Cancer Patients' Attitudes Unrelated to Survival -
Reuters 11_08_02
|
| Cancer battle can be trampoline of highs, lows -
R. Clark, Pioneer Press
"This is going to be a hard letter for me to write," he began his e-mail. He was tipping his hand early. Turns out he had found a lump in a lymph node under his jaw while showering recently. He will have surgery Sept. 20 to remove the mass. His doctors are certain the cancer is back."
|
| Scientists to Study Red Wine for Anti-Cancer Drug
- Reuters 11_05_02
"... possible new cancer prevention drug based on resveratrol, a natural compound found in red wine. "
|
| Early research: Vaccine 'starves cancer cells' -
BBC News 11_05_02
Caveat: "It must be a concern if you deliver permanent immunity against the production of blood vessels."
|
| Study: Some Herbal Meds Interfere with Cancer Drug -
Reuters 11_05_02
|
| Smoking May Change Type Of Lymphoma Into More Lethal Form Of Cancer -
eurekalert.org
11_01_02
|
| ICML: Quantification of Circulating t(14;18)+ Cells Predicts Response to Rituximab Therapy in Follicular Lymphoma Patients -
Docguide.com
6_18_02
|
| Psychological Stress Does Not Cause Cancer: Study -
Reuters 10_30_02
|
| NCI Initiates
Trial of Genasense(TM) Plus Rituxan In Patients With
Non-Hodgkin's Lymphoma - Prnewswire
10_30_02
From Prnewswire, use Search button and key word Genasense to
locate.
|
| How many Cts are too many? Putting long-term
risks into perspective - Update
10_29_02
|
| Scientists have found a way to harvest more
stem cells from a baby's umbilical cord. - BBC
News 10_22_02
|
| Regular exercise could both help people avoid
developing cancer, or help them make a more successful recovery,
say scientists - BBC
News 10_18_02
|
| Rituximab as First-Line and Maintenance
Therapy for Patients With Indolent Non-Hodgkin's Lymphoma. J
Clin Oncol. 2002 Oct 15;20(20):4261-7.
PMID: 12377971 - PubMed
|
| Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells
vs. bone marrow in allogeneic recipients: long-term follow-up of a randomized trial -
Blood, 15_July_2002 (lost link)
|
| Smallpox vaccine & NHL: Information on Live Virus Vaccines and Vaccinia -
cdc.gov
| Also see Immunization guide
|
| Magnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies -
Blood, Vol. 90 No. 6 9_15_97
|
| Zevalin Safe For Patients Who Have Had Prior
Radiation - OncoLink
10-9-02 2002
|
|
Sequencing of Therapies for Low-Grade Lymphomas - cancercare.org
Presenter: Peter Rosen, MD, Professor of Medicine, UCLA School of Medicine, Department of Hematology and Oncology, Los Angeles, CA.
|
|
OVERCOMING REFRACTORY DISEASE: Bendamustine in the
treatment of non-Hodgkin's lymphoma: results and future
perspectives. Semin Oncol. 2002 Aug;29(4 Suppl 13):27-32. Review.
PMID: 12170430 - PubMed
|
|
FDA Launches Plan to Reduce Acrylamides in Foods, -
Reuters 9-30-02
|
| Evaluation of the Risk of Therapy-Related
MDS/AML After Autologous Stem Cell Transplantation - HTML
Biology of Blood and Marrow Transplantation 8:9-16 (2002)
|
| Response to thalidomide in
chemotherapy-resistant mantle cell lymphoma: a case report. Br J
Haematol. 2002 Oct;119(1):128-30.
PMID: 12358916 - PubMed
|
| Mini Transplants Appear Effective for Some Patients who Relapse Following Autologous Stem Cell Transplants
- CancerConsultants.com
10-07-02
|
|
Subsequent Therapy Well Tolerated in Patients
Previously Treated with
Zevalin (tm) - 411cancer.com
Sep_02
|
|
|
|
Rare Disorder Provides New Insight Into Fighting
Infection - NIH
Sep_25
"Caspase-8 deficiencies might explain why some people don't
respond as well as others to vaccines, or why some people's immune
systems don't fight off infections as well as others."
|
| Rituxan + steriods: Glucocorticoids and rituximab in
vitro: synergistic direct antiproliferative and apoptotic effects.
Blood. 2002 Sep 1;100(5):1765-73. PMID: 12176898 - PubMed
|
| Sewage Yields Clues to SV40 Transmission - JAMA
Sep_18
|
| Photopheresis Followed by Immunotherapy Improves Responses in Cutaneous
T-Cell Lymphoma - 411cancer.com
|
| Cancer Cells Killed in Test Therapy - Health
AP
|
|
Fact Sheet: West Nile Virus Infection in Organ Transplantation and
Blood
Transfusion Recipients - cdc.gov
|
|
GenOdyssee Announces Positive Results of Proprietary
Interferon-alpha Variants for the Treatment of Hepatitis C and Cancer
- Sep_05
- In Preclinical Disease Models Variants Demonstrate Increased
Efficacy Compared to Those Currently Available on the Market - nrp-euro.com
|
|
Immunological and molecular analysis of B lymphocytes in low-grade
MALT lymphoma of the stomach. Are there any useful markers for
predicting outcome after Helicobacter pylori eradication?
J Gastroenterol. 2002;37(6):428-33. PMID: 12108676 - PubMed
|
|
Cancer Vaccines for Hematologic Malignancies: Ivan M. Borrello, MD, Eduardo M. Sotomayor, MD -
Medscape Free login req.
|
| Oxaliplatin Appears Effective (as cisplatin) in Treatment Regimen
for Recurrent NHL - CancerConsultants.com
"This news item was actually published in December, but we posted
it recently because oxaliplatin was just FDA approved for colorectal
cancer."
|
|
Monoclonal Antibody Therapy in B-Cell-Related Disorders and
Malignancies CME Authors: Sandra J. Horning, MD and Robert S.
Mocharnuk, MD - Medscape
free login req.
|
| Optimizing Anti-CD20 Immunotherapy of
Lymphomas and Chronic Lymphocytic Leukemia, D. G. Maloney, MD,
PhD, R. Mocharnuk, MD - iwmf.com
|
| Phase II trial of interferon-alpha-2a plus psolaren with
ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer
2002; 95: 569-75. - PubMed
|
| Immune Factors May Influence Post-Cancer Fatigue - Reuters
Sep_2
|
| Enhanced killing of B lymphoma cells by granulocyte
colony-stimulating factor-primed effector cells and Hu1D10 - a
humanized human leucocyte antigen DR antibody. Br J Haematol. 2002
Sep;118(4):959-67.
PMID: 12199773 - PubMed
|
| Red Wine Consumption Associated with Reduced Risk of
Non-Hodgkin's Lymphoma - 411cancer.com
Aug_2
|
| High-Dose Chemotherapy and Autologous Stem Cell Transplantation
Improves Responses in Advanced Follicular Lymphoma - 411cancer.com
Aug_2
|
| Zevalin (tm) Effective in Recurrent Follicular Lymphoma - 411cancer.com
|
|
|
| Recommended reading:
NHL-specific "When to Consider a Clinical Trial" - Dr.
David B. Miklos M.D., Ph.D. (Verites)
|
| St John’s wort interferes with chemotherapy, study shows - BMJ
Aug_31
|
| Clinical trials specific to Diffuse Large Cell Lymphoma - New
Content on PAL Aug_28
|
| Management of Cancer in the Elderly - mmhc.com
|
| Report Cites 'Dangerous' Cancer Advice on Web - Reuters
Aug_20
|
| St. John's Wort Weakens Cancer Drug's Effect - Reuters
Aug_20
|
| Scientific presentations vary from 35-60 minutes in length. They
provide research reviews usually given at the Moffitt Cancer Center
facility. - H. Lee Moffitt
Cancer Center & Research Institute Req. Windows Media Player
|
| Use of Complementary/Integrative Nutritional Therapies During
Cancer Treatment: Implications in Clinical Practice - Medscape
2002 H. Lee Moffitt Cancer Center and Research Institute, Inc.
|
| Intrathecal Chemotherapy may Reduce Cancer Recurrences in
Aggressive Non-Hodgkin's Lymphoma - 411cancer.com
Aug_02
|
| Low-Dose Radiation plus Donor Lymphocyte Infusion Produces
Responses in Refractory Hematologic Cancers - 411cancer.com
Aug_02
|
| New Links Between Cancer and Gene p27 - Oncology
News Aug_6
|
| Clinical trial participation is crucial to fight cancer -
SHERRY LANSING AND NORMAN SCHWARZKOPF Jul_26 - Pioneer
Press
|
| Phase II immunotherapy trial launched in CLL: a Phase II
immunotherapy trial with Tragen Pharmaceuticals' lead product, ISF154,
has been launched in chronic lymphocytic leukaemia (CLL) - press
release
|
|
FDA Grants Orphan Drug Status to Oncophage® Vaccine for
Metastatic Melanoma - CancerConsultants.com
|
|
Advantages of positron emission tomography (PET) with respect to
computed tomography in the follow-up of lymphoma patients with
abdominal presentation. Leuk Lymphoma. 2002 Jun;43(6):1239-43.
PMID: 12152991- PubMed
|
|
Cancer treatments now come in pill form - Philadelphia
Inquirer Aug_5
|
|
Controversy hides drug's advantages St.
Petersburg Times July_30
ImClone's insider trading scandal has drawn more attention than its
promising cancer treatment has.
|
|
Progress and promise in the treatment of indolent lymphomas.
Oncologist. 2002;7(3):217-25. Review. PMID: 12065794 - PubMed
|
|
Tobacco as Cancer Research Tool
: Plants Aid in Development of a Vaccine to Fight Tumors - By
Justin Gillis
Washington Post Staff Writer July_22_2002
|
|
SV40 virus UPDATES - SLIDES
& PRESENTATIONS : SV40 Contamination of Polio Vaccine
and Cancer Meeting Agenda - PAL Presentations by experts July 11, 2002 National Academy of Sciences
|
|
CLINICAL TRIALS UPDATE: Quickly find NHL-specific clinical trial
listings from the ClinicalTrials.gov database - PAL
7_23 Locate trials by treatment type, or for many other criteria
with just one click.
|
|
Dying Cancer Patients Want Straight Info from Docs - Reuters
Jul_22
|
| US Government, Industry Move to Speed Cancer Trials
- Reuters
Jul_23
|
| FDA
APPROVES AMGEN'S ARANESP™ FOR ANEMIA ASSOCIATED WITH CHEMOTHERAPY - PR Newswire
Jul_22
|
| Wall Street Journal reports on SV40 virus
connection to NHL. See SV40 virus
issues updates. 7_22_02
"In several tumors, it was precisely the genome of the SV40
in the vials of the 1955 polio vaccine that Dr. Ratner had held
onto, waiting for someone to care. Lab-grown SV40 harbors a
variant genome. There might be other sources, in addition to
vaccine, of this strain of SV40, but to more and more scientists
Dr. Butel's findings were the smoking gun." - WSJ 7-19-02
|
|
Anti-Cancer Compound Found in Malaysian Plant (Eurycoma
longifolia) - Reuters
7_22 Related
Abstracts
|
|
NEW TREATMENT AGENT: GENTA INITIATES NEW CLINICAL
PROGRAM FOR GALLIUM NITRATE IN NON-HODGKIN’S LYMPHOMA
- Genta
"An important property of gallium is that it appears to display
preferential targeting to lymphoma cells and, unlike most
chemotherapeutic drugs, it does not suppress the bone marrow."
|
| The Fight to Keep 'Direct-to-Consumer Ads' for drugs - NY_Times
Jul_12
PAL Note: Does this kind of promotion drain financial resources
away from development of drugs to treat life threatening cancers? Does
it increase incentives to develop more "me-too" drugs of
questionable value?
|
| Cancer Patients Get Inadequate Care for Pain: Panel - Reuters
Jul_17
|
|
Health Info on Web Often Not Backed by Science - Reuters
Jul_16
|
| RESEARCH: Beyond immunochemotherapy: combinations of rituximab
with cytokines interferon-alpha2a and granulocyte-macrophage colony
stimulating factor. Semin Oncol. 2002 Apr;29(2 Suppl 6):7-10. Review.
PMID: 12040528 - PubMed
|
| US Panel Says No Amount of Trans Fat Is Safe - Reuters
Jul_15
Note: Trans fats have been linked to increased risk of NHL - PAL
|
|
Many Cancer Patients Use Complementary Therapies - Reuters
July_15
|
|
ANEMIA RECOMMENDATION: Management of disease-related anemia in
patients with multiple myeloma or chronic lymphocytic leukemia:
epoetin treatment recommendations. Hematol J. 2002;3(3):121-30. PMID:
12111647 - PubMed
|
|
DRUG TOXICITY INFO: Analysis of age, estimated creatinine
clearance and pretreatment hematologic parameters as predictors of
fludarabine toxicity in patients treated for chronic lymphocytic
leukemia: a CALGB (9011) coordinated intergroup study. Cancer
Chemother Pharmacol. 2002 Jul;50(1):37-45. PMID: 12111110 - PubMed
|
|
DRUG INFO: Splenic lymphoma in presence of HCV may respond to
interferon alpha - Reuters
Health Jul_10
|
|
RESEARCH NEWS: Cytokine improves immune function after bone marrow
transplantation in mice - Reuters
Health
|
|
RESEARCH NEWS: Simian 40 virus seen as entrenched in humans, but oncogenicity
disputed - Reuters
Health Jul_11
|
|
ALERT: J&J WARNS OF RARE BLOOD DISORDER RISK FROM
EPREX
Johnson & Johnson on Thursday said the number of patients who have
developed a rare blood disorder when treated with the firm's anemia
drug has risen to 124 worldwide and 1 of those patients died.
Reuters Health Information 2002 - Medscape
|
|
FEW LEUKEMIC CHILDREN DEVELOP SECOND NEOPLASMS
Follow-up of children successfully treated for acute Lymphoblastic
leukemia (ALL) indicates that the incidence of second neoplasms is
low.
Reuters Health Information 2002 - M
July_11
|
|
RESEARCH ABSTRACT: Fully human, HLA-DR-specific
monoclonal antibodies efficiently induce programmed death of malignant
lymphoid cells. Nat Med. 2002 Jul 8 PMID: 12101408 - PubMed
|
|
RESEARCH PRESS: Cancer research focuses on tumors' DNA
- By Raja Mishra, Globe
Staff, July_8
|
|
DRUG INFO: - Zevalin: IDEC
| Rituxan: - IDEC
|
|
DRUG INFO: Zevalin Reimbursement Support - IDEC
Information on how to navigate through the complex maze of
health insurance requirements
|
| RESEARCH PRESS: Scientists may be on the verge of curing some of the most deadly
and crippling diseases that plague man, experts said Sunday during
MSNBC TV’s “Summit for a Cure.” - MSNBC
Jun_24
|
| Corixa to present BEXXAR data at future ODAC meeting Jun_26
|
| DRUG DATA: Dose-adjusted EPOCH chemotherapy for untreated large B-cell
lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002
Apr 15;99(8):2685-93. PMID: 11929754 - PubMed
|
| Technical: Consequences of cell death: exposure to necrotic
tumor cells, but not primary tissue cells or apoptotic cells, induces
the maturation of immunostimulatory dendritic cells," Journal of
Experimental Medicine - PDF
| PDF-Help
|
| Product R, a "switch type"
immunomodulator, will be tested in lymphoma pts with symptoms of
cachexia - Oncology
News Jun_17
|
| Inhibitor of the enzymatic activity of telomerase (GRN163)
active against Myeloma and Lymphoma - Oncology
News Jun_18
|
| Rituximab (especially extended use) Delays Indolent NHL
Progression - Oncology
News Jun_18
|
| PET Scans Better Than Standard Gallium Scan - ACS
News Today Apr_2002
|
| Investigational Data From Randomized Study of Extended Therapy
With Rituxan Demonstrates Potential to Delay Disease Progression in
Patients With Indolent NHL - Genentech
Jun_17
|
| The Psychology of Cancer By: Harvey Max
Chochinov, MD, PhD By: Sherry Schachter, PhD, RN - Healthology
Jun_18
|
| Mantle Cell treatment effective - BBCNews
Jun_17
|
|
ALERT: The Leukemia &
Lymphoma Society is warning pts and
healthcare professionals to avoid using a counterfeit lot of PROCRIT
brand of epoetin alfa, a drug used to treat anemia. For more
information, please visit www.procrit.com/counterfeit/letter.html
or call the Society's Information Resource Center at (800) 955-4572, 9
a.m. to 6 p.m. EST, Monday to Friday.
|
|
Officials Press U.S. Congress for Cancer Tracking - Press
Jun_13
"WASHINGTON (Reuters Health) - Public health officials pushed the
US Congress Thursday to approve plans for a nationwide disease
tracking system designed to detect cancer clusters and other disease
outbreaks possibly caused by environmental toxins."
|
| Automating patients-specific treatment: Favrille
sets sights on Rituxan - Press
release Jun_14
|
|
'Trojan horse' technology destroys blood supply to cancer tumors
in mice - eurekalert.org
"Researchers at The University of Texas M. D. Anderson Cancer
Center in Houston and The University of Texas Southwestern Medical
Center at Dallas have demonstrated in mice that a new drug formed by
linking a vascular endothelial growth factor to a toxin will target
and destroy the blood vessels supplying a malignant tumor.
|
| Scientists Become Filmmakers to Decipher Immunity - NIAID
"According to Dr. Germain, the new technique will permit
investigators to explore questions they previously could not clearly
address: for example, how long do T cells remain in contact with their
target cells, when do the T cells divide, and where do different types
of T cells go once they have been activated."
|
| Epoetin therapy is effective against anemia
- Randomized, double-blind, placebo-controlled trial of
recombinant human erythropoietin, epoetin Beta, in hematologic
malignancies. J Clin Oncol. 2002 May 15;20(10):2486-94. PMID: 12011126
abstract
|
| The FDA has amended its new drug and biological product
regulations so that certain human drugs and biologics that are
intended to reduce or prevent serious or life-threatening conditions
may be approved for marketing based on evidence of effectiveness from
appropriate animal studies when human efficacy studies are not ethical
or feasible. Summary
| PDF
| PDF-Help
|
| Immunotherapy Shows Promise for Non-Hodgkin's Lymphoma - Medscape
May_20 "The goal is really to delay or prevent the need for
chemotherapy," said study author Dr. John Timmerman, an assistant
professor of medicine at the University of California, Los Angeles.
|
|
Patients in cancer drug plea Tuesday, 28
May, 2002 - news
UK
|
|
|
| Occupation and risk of non-Hodgkin's lymphoma and chronic
lymphocytic leukemia. J Occup Environ Med. 2002 May;44(5):469-74. PMID:
12024692 PubMed
abstract
|
| What Are Clinical Trials For? - Oncology
News May_22
"The researchers stated that these findings suggest that there is
a "provocative view in oncology that clinical trials perfectly
harmonize the objectives of treatment and research." Further,
they stated that the conviction that studies are directed mainly to
benefit participants challenges the commonly held opinion that
research is conducted for scientific knowledge and the improvement of
therapy given in the future."
|
| RADIO-IMMUNOTHERAPY: NEW DEVELOPMENTS IN LYMPHOMA TREATMENT, by
Julie Vose, MD a free teleconference, Tuesday June 18, 2002, 1
PM-2 PM ET. For more info call 1800 813-HOPE or (212)
712-8080 or register online at www.cancercare.org
|
| UNDERSTANDING CANCER PATIENTS' NEEDS, CONCERNS IS KEY TO
IMPROVING CLINICAL TRIAL PARTICIPATION - UC
Davis CC May_20
|
|
Immunomedics Announces Additional Interim Results of
Epratuzumab Combination In Treating Non-Hodgkin's Lymphoma - PR
Newswire May_20
|
|
Experimental Therapy, End-of-Life Care Can Coexist
Tue May 21, 7:12 PM ET -
HealthScoutNews
"In the past, it's been an either-or situation: Seriously ill
patients have been told they can have a clinical trial or they can go
home and focus on quality of life,"
|
| The All-Cancer Film Festival - "A patient in chemotherapy
surveys the genre." By Gary Sperling - culturebox
May_20
|
| Solving The Drug Patent Problem - Forbes
May_21
|
|
FDA
Continues Bexxar Approval Quest May_16
Officials from Corixa recently met with representatives from the US
Food and Drug Administration about the company's biologics license
application for tositumomab (Bexxar) as a treatment for relapsed,
refractory non-Hodgkin's lymphoma.
|
|
Unresponsive
NHL Patients Respond to Zevalin May_13
Scientists at the Mayo Clinic reported that patients diagnosed with
non-Hodgkin's lymphoma who did not respond to standard treatment
responded to ibritumomab (Zevalin)
|
|
|
| STILL VITAL: BLOOD CANCER ADVOCACY
ACTION:
Write!
e-mail Letter - LRF -- This EASY action sends a prewritten letter to all your representatives
in one step. PLEASE HELP by clicking the link above. NOTE: Be
sure to click in and edit the paragraphs in each letter to
describe your personal connection (patient, caretaker, loved one).
|
| Cancer Treatment: Determining the Best
Long-Term Plan for You - PDF
| PDF-Help
- Maloney, Cha (Highly recommended. Requires Adobe
Acrobat reader.)
|
| Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic
factors and risk allocation. Curr Oncol Rep. 2002 Mar;4(2):107-13. Review.
|
|
|
| Can cancer drug heal
Millennium? Biotech firm betting on
experimental drug to revive hopes press
release May_3 (potential NHL drug - PS 341)
|
|
|
| Blood cancer efforts get lift --
Hutchison's bill to aid research heads to White House press
release apr_30
|
| Using Antisense, Monoclonal, and Standard Chemotherapy All
Together - BioNews
"Genta (NASDAQ: GNTA) announced the initiation of a multicenter
clinical trial in patients with mantle cell lymphoma (MCL)" Feb
2002
|
| Cancer Risk Found in French Fries, Bread
- Reuters Apr_24
"Findings unveiled at a news conference called by the food
administration showed that an ordinary bag of potato chips may contain
up to 500 times more of the substance (acrylamide) than the top
level allowed in drinking water by the World Health Organization"
|
| Clinical trials: They're Dying to Get In
- Time
Apr_24
|
|
Clinical trials: Questions to Ask Your
Doctor & More Resources - Time
Apr_24
|
| Higher incidence of cancer seen in young
adults: Report
Last Updated Thu, 18 Apr 2002 19:10:38 - TORONTO press
release "non-Hodgkin's lymphoma increased 3.5 per cent among women
and 4.0 per cent among per year" Apr_18
|
| Despite Billions for Discoveries, Pipeline
of Drugs Is Far From Full - press
Apr_19
|
| Patient-Doc Communication
Key to Cancer Pain Relief - press
|
| Cancer Vaccine Shows Promise Against Brain
(and other) Tumor - press
release " . . . the concept is that you could take a human tumor, engineer that, flagging it somehow, and then injecting it back into the human to trigger an immune
response" Apr_16
|
| Getting Used to Life, Long Life,
With Cancer - NY
Times Reg req.
"Some with cancer say that, if you want to know what it's like to
be given a diagnosis of a serious malignancy, think of Sept. 11.
"On that day, 280 million Americans had the same sense of shock
and disbelief that a person feels when told they have cancer,"
said the woman with lymphoma, who asked to remain anonymous. "You
feel that it can't be happening, it can't be real." In a single
day, she said, "your innocence is lost and your sense of security
shattered," and regardless of what happens, it will never be
Sept. 10 again." Apr_16
|
| Cancer Patients Need Weight Kept On - AP
press Apr_11
|
| Drug (phenoxodiol) stabilizes cancer growth minus side effects - CNN.com
Health Apr_11
|
